$59.58 +0.60 (1.02%) Merck & Co Inc - NYSE

Dec. 19, 2014 | 04:00 PM
Key Statistics
Last Trade: 59.58
Trade Time: Dec 19 04:00 PM Eastern Daylight Time
Change: +0.60 (1.02%)
Prev Close: 58.98
Open: 59.25
Bid: 59.45
Ask: 59.67

Competitors

Ticker Name Volume % Change
PFE Pfizer Inc 44.95M -0.09%
JNJ Johnson & Johnson 19.15M -1.18%
IMGN Immunogen Inc 16.59M -43.69%
AVNR Avanir Pharmaceuticals Inc 13.89M -0.82%
XOMA Xoma Corp 12.96M -5.65%

MRK Stock Analysis

Partner Headlines

  1. Tetraphase Jumps As 'Superbug' Drug Scores In Trial

    IBD | Dec. 18, 2014 | 11:54AM EST
  2. Druckenmiller Adds Healthcare Stocks to Portfolio

    GuruFocus | Dec. 15, 2014 | 16:57PM EST
  3. Lilly Upgraded On 2 Potential Blockbuster Drugs

    IBD | Dec. 11, 2014 | 14:25PM EST
  4. Market Mixed Amid Plan To Spend $300 Million On Ebola Vaccines

    Benzinga | Dec. 11, 2014 | 14:14PM EST
  5. Celgene's Abraxane Succeeds In Early Breast Cancer

    IBD | Dec. 11, 2014 | 11:27AM EST
  6. Merck repurposes cancer drug

    IBD | Dec. 10, 2014 | 18:43PM EST